HCS Pharma

biomimesys 3d cell culture hcs drugs discovery liver high content screening cell genotoxicity drug ecm brain 3d culture toxicity parkinson startup organoids 3d cell phenotypic screening hydroscaffold comet assay cancer neurotoxicity hepg2 biotechnologie health hepatocyte hipscs organ-on-chip chip microenvironment 3d metabolic culture 3d sante sh-sy5y virtual reality visualization augmented reality human statins ldl stem cells drugs pcsk9 dna damage biotechnology elrigfr phosphorylation γh2ax entreprise biotech forum labo prix forum steatosis hcs pharma cellule rennes presse organs on chip pancreas therapy lung pluripotent research genotypes ipscs protection parkinson's disease neurosciences neurology neurocell3d drug discovery biomimesys brain 3d fluorescence livre organ stiffness breast cancer hyaluronic acid bretagne ouest investissement fond hcspharma microenvironnement 2019 parís market pharmaceutical hepatocytes heparg innovcell3d strasbourg hipsc biofunctionalized ncardia ips scaffold collagen adipocyte 3d model medicament cell culture cellular models comet genetoxicity assay h2ax micronucleus big data future biology keratinocyte "in vitro" dermocosmetology fibroblast primary human keratinocytes cosmetic high throughput genotoxic high content imaging e-sante recherche public collaboration entreprendre eentreprise réseau concours double strand break skin tumor dna damaging eukaryotic cells blood brain barrier automation laboratory scratch assay cell death effect anti-cancer drugs wound healing dna micronuclei biologie femme trophée pharmacie économie neuroprotection telford phospholipidosis co-culture microglia model elrig disease dijon afsii elevator pitch presentation innovation celenys 2015 biomimetix salon dossier labo hepatoma atalante création externe